Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death

Europace

Volumn 18, Issue 12, 2016, Pages 1818-1828

  Demazumder, Deeptankar ^a   Limpitikul, Worawan B ^a   Dorante, Miguel ^a   Dey, Swati ^a   Mukhopadhyay, Bhasha ^a   Zhang, Yiyi ^b   Randall Moorman, J ^c   Cheng, Alan ^a   Berger, Ronald D ^a   Guallar, Eliseo ^b   Jones, Steven R ^a   Tomaselli, Gordon F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Chaos theory; Heart failure; Heart rate variability; Non linear dynamics; QT variability; Risk prediction; Sudden cardiac death

Indexed keywords

ADULT; AFRICAN AMERICAN; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; ENTROPY; FEMALE; HEART EJECTION FRACTION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PRIMARY PREVENTION; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SINUS RHYTHM; SUDDEN CARDIAC DEATH; SURVIVAL PREDICTION; TREATMENT INDICATION; AGED; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; HEART FAILURE; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AGED; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ENTROPY; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 85018337968     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv399     Document Type: Review

References (35)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
2. Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverterdefibrillator: the need for improved risk stratification. JAMA 2005;294:958-60.
3. Goldberger AL. Fractal electrodynamics of the heartbeat. Ann N Y Acad Sci 1990;591:402-9.
4. Kaplan DT. The analysis of variability. J Cardiovasc Electrophysiol 1994;5:16-9.
5. Buchman TG. The community of the self. Nature 2002;420:246-51.
6. Moorman JR, Carlo WA, Kattwinkel J, Schelonka RL, Porcelli PJ, Navarrete CT et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr 2011;159:900-6.
7. Demazumder D, Lake DE, Cheng A, Moss TJ, Guallar E, Weiss RG et al. Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias. Circ Arrhythmia Electrophysiol 2013;6:555-61.
8. Perkiomaki JS, Couderc JP, Daubert JP, Zareba W. Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators. Pacing Clinl Electrophysiol 2003;26:1931-6.
9. Lipsitz LA, Goldberger AL. Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. JAMA 1992;267:1806-9.
10. Goldberger AL, Amaral LA, Hausdorff JM, Ivanov P, Peng CK, Stanley HE. Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci USA 2002;99(Suppl. 1):2466-72.
11. Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000;101:47-53.
12. Makikallio TH, Hoiber S, Kober L, Torp-Pedersen C, Peng CK, Goldberger AL et al. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. TRACE Investigators. TRAndolapril Cardiac Evaluation. Am J Cardiol 1999;83:836-9.
13. Sassi R, Cerutti S, Lombardi F, Malik M, Huikuri HV, Peng CK et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace 2015;17:1341-53.
14. Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T et al. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc 2013;2:e000083.
15. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-33.
16. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-65.
17. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-65.
18. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998;9:899-908.
19. Haigney MC, Kop WJ, Alam S, Krantz DS, Karasik P, DelNegro AA et al. QT variability during rest and exercise in patients with implantable cardioverter defibrillators and healthy controls. Ann Noninvasive Electrocardiol 2009;14:40-9.
20. Myredal A, Gao S, Friberg P, Jensen G, Larsson L, Johansson M. Increased myocardial repolarization lability and reduced cardiac baroreflex sensitivity in individuals with high-normal blood pressure. J Hypertension 2005;23:1751-6.
21. Buchman TG. Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care 2004;10:378-82.
22. Lake DE. Renyi entropy measures of heart rate Gaussianity. IEEE Trans Biomed Eng 2006;53:21-7.
23. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012;176:473-81.
24. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 1996;24:1107-16.
25. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18.
26. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992;85:I2-10.
27. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med 2008;168:136-40.
28. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007;298:1517-24.
29. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
30. Rashba EJ, Estes NA, Wang P, Schaechter A, Howard A, Zareba W et al. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 2006;3:281-6.
31. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 2003;41:2220-4.
32. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003;108:2883-91.
33. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S et al. Utility of the Seattle heart failure model in patients with advanced heart failure. J Am Coll Cardiol 2009;53:334-42.
34. DeMazumder D, Kass DA, O'Rourke B, Tomaselli GF. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling. Circ Res 2015;116:1691-9.
35. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009;9:418-28.